Coriell Institute | GenomeWeb

Coriell Institute

The cell lines were edited with CRISPR/Cas9 to create fusions of GFP with the proteins of interest, allowing researchers to image structures in real time.

The new grant provides Coriell with funding for five years to maintain the repository of cell lines, DNA, and genotype and sequence data.

The medical research institute is licensing the technology in order to develop future versions of it, and add new functions and services.

Researchers now have access to 300 pluripotent stem cell lines to study disease.

The award will support a collection of biosamples used in aging research and housed at the institute.

The grant from the National Institute of General Medical Sciences will support a biobank with cell lines and DNA samples representing 890 diseases.

NEW YORK (GenomeWeb) – The National Institute of General Medical Sciences plans to provide up to $2.8 million next year to fund the NIGMS Human Genetic Cell Repository.

NEW YORK (GenomeWeb) – Agilent Technologies said this week that it has inked a partnership with South Korea's Center for Women in Science, Engineering and Technology to help advance women scientists and engineers in that country.

NEW YORK (GenomeWeb News) – The Coriell Institute for Medical Research is launching a biobank on the West Coast that will house induced pluripotent stem cell lines, and is using a $10 million grant from the California Institute of Regenerative Medicine to fund the facility.

NEW YORK (GenomeWeb News) – The Coriell Institute for Medical Research recently announced a $7.7 million contract extension from the National Institute for Neurological Disorders and Stroke to maintain the institute's biobank.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.